Literature DB >> 22819362

Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology.

Ken B Waites1, Li Xiao, Vanya Paralanov, Rose M Viscardi, John I Glass.   

Abstract

Mycoplasma and Ureaplasma species are well-known human pathogens responsible for a broad array of inflammatory conditions involving the respiratory and urogenital tracts of neonates, children, and adults. Greater attention is being given to these organisms in diagnostic microbiology, largely as a result of improved methods for their laboratory detection, made possible by powerful molecular-based techniques that can be used for primary detection in clinical specimens. For slow-growing species, such as Mycoplasma pneumoniae and Mycoplasma genitalium, molecular-based detection is the only practical means for rapid microbiological diagnosis. Most molecular-based methods used for detection and characterization of conventional bacteria have been applied to these organisms. A complete genome sequence is available for one or more strains of all of the important human pathogens in the Mycoplasma and Ureaplasma genera. Information gained from genome analyses and improvements in efficiency of DNA sequencing are expected to significantly advance the field of molecular detection and genotyping during the next few years. This review provides a summary and critical review of methods suitable for detection and characterization of mycoplasmas and ureaplasmas of humans, with emphasis on molecular genotypic techniques.
Copyright © 2012 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22819362      PMCID: PMC3427874          DOI: 10.1016/j.jmoldx.2012.06.001

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  97 in total

Review 1.  Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections.

Authors:  K Loens; D Ursi; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Detection of Mycoplasma pneumoniae by real-time nucleic acid sequence-based amplification.

Authors:  K Loens; M Ieven; D Ursi; T Beck; M Overdijk; P Sillekens; H Goossens
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

3.  Diagnostic utility and clinical significance of naso- and oropharyngeal samples used in a PCR assay to diagnose Mycoplasma pneumoniae infection in children with community-acquired pneumonia.

Authors:  Ian C Michelow; Kurt Olsen; Juanita Lozano; Lynn B Duffy; George H McCracken; R Doug Hardy
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

4.  Simultaneous detection and identification of common cell culture contaminant and pathogenic mollicutes strains by reverse line blot hybridization.

Authors:  Hui Wang; Fanrong Kong; Peter Jelfs; Gregory James; Gwendolyn L Gilbert
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

5.  Association of Ureaplasma urealyticum (biovar 2) with nongonococcal urethritis.

Authors:  Takashi Deguchi; Takashi Yoshida; Takamaro Miyazawa; Mitsuru Yasuda; Masayoshi Tamaki; Hiroaki Ishiko; Shin-Ichi Maeda
Journal:  Sex Transm Dis       Date:  2004-03       Impact factor: 2.830

Review 6.  Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases.

Authors:  Jørgen Skov Jensen
Journal:  J Eur Acad Dermatol Venereol       Date:  2004-01       Impact factor: 6.166

7.  Use of TaqMan 5' nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic.

Authors:  Jørgen Skov Jensen; Eva Björnelius; Birthe Dohn; Peter Lidbrink
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

8.  Use of an oligonucleotide array for laboratory diagnosis of bacteria responsible for acute upper respiratory infections.

Authors:  Stina B Roth; Jari Jalava; Olli Ruuskanen; Aino Ruohola; Simo Nikkari
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

9.  Comparison and evaluation of real-time PCR, real-time nucleic acid sequence-based amplification, conventional PCR, and serology for diagnosis of Mycoplasma pneumoniae.

Authors:  Kate E Templeton; Sitha A Scheltinga; A Willy Graffelman; Jolanda M Van Schie; Jantine W Crielaard; Peter Sillekens; Peterhans J Van Den Broek; Herman Goossens; Matthias F C Beersma; Eric C J Claas
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

10.  Detection and quantification of Mycoplasma genitalium in male patients with urethritis.

Authors:  Nicolas Dupin; Gérard Bijaoui; Michaël Schwarzinger; Pauline Ernault; Philippe Gerhardt; Randa Jdid; Salim Hilab; Christina Pantoja; Marc Buffet; Jean-Paul Escande; Jean-Marc Costa
Journal:  Clin Infect Dis       Date:  2003-07-30       Impact factor: 9.079

View more
  40 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Molecular Detection of Ureaplasma urealyticum from Prostate Tissues using PCR-RFLP, Tehran, Iran.

Authors:  Gholamreza Irajian; Mehri Sharifi; Shiva Mirkalantari; Reza Mirnejad; Mohammad Reza Jalali Nadoushan; Nafiseh Ghorbanpour
Journal:  Iran J Pathol       Date:  2016

3.  Diagnosis of ureaplasma urealyticum septic polyarthritis by PCR assay and electrospray ionization mass spectrometry in a patient with acute lymphoblastic leukemia.

Authors:  Marie Balsat; Lionel Galicier; Alain Wargnier; Sabine Pereyre; Raphaël Itzykson; Myriem Zouakh; Cécile Bébéar; Nicolas Boissel
Journal:  J Clin Microbiol       Date:  2014-06-23       Impact factor: 5.948

4.  Evaluation of five real-time PCR assays for detection of Mycoplasma pneumoniae.

Authors:  Roger Dumke; Enno Jacobs
Journal:  J Clin Microbiol       Date:  2014-09-10       Impact factor: 5.948

5.  Evaluation of the ELITe InGenius PCR Platform for Detection of Mycoplasma pneumoniae.

Authors:  Arthur H Totten; Sixto M Leal; Amy E Ratliff; Li Xiao; Donna M Crabb; Ken B Waites
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

6.  Evaluation of a real-time PCR assay for detection of Mycoplasma genitalium and macrolide resistance-mediating mutations from clinical specimens.

Authors:  Li Xiao; Ken B Waites; Hong Wang; Barbara Van Der Pol; Amy E Ratliff; William M Geisler
Journal:  Diagn Microbiol Infect Dis       Date:  2018-02-09       Impact factor: 2.803

7.  Evaluation of the Virclia® automated chemiluminescent immunoassay system for diagnosing pneumonia caused by Mycoplasma pneumoniae.

Authors:  Victoria Ortiz de la Tabla; Marta Berruezo; Elena García Payá; Marta Fernández; José Alberto García; Mar Masiá; Félix Gutiérrez
Journal:  J Clin Lab Anal       Date:  2018-03-06       Impact factor: 2.352

Review 8.  Role of Ureaplasma Respiratory Tract Colonization in Bronchopulmonary Dysplasia Pathogenesis: Current Concepts and Update.

Authors:  Rose Marie Viscardi; Suhas G Kallapur
Journal:  Clin Perinatol       Date:  2015-10-09       Impact factor: 3.430

9.  Evaluation of Commercial Molecular Diagnostic Methods for Detection and Determination of Macrolide Resistance in Mycoplasma pneumoniae.

Authors:  Sixto M Leal; Arthur H Totten; Li Xiao; Donna M Crabb; Amy Ratliff; Lynn B Duffy; Karen B Fowler; Emily Mixon; Jonas M Winchell; Maureen H Diaz; Alvaro J Benitez; Bernard J Wolff; Xuan Qin; Y-W Tang; Mark Gonzalez; Raj Selvarangan; Tao Hong; Edward Brooks; Steve Dallas; T Prescott Atkinson; Xiaotian Zheng; Jennifer Dien Bard; Ken B Waites
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

Review 10.  Ureaplasma species: role in neonatal morbidities and outcomes.

Authors:  Rose Marie Viscardi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2013-08-19       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.